← Eichor
Study identifier: NCT04153032 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Comparative Evaluation of MEBO Ointment and Topical Diltiazem Ointment in the Treatment of Acute Anal Fissure

Condition: Anal Fissure  ·  Sponsor: American University of Beirut Medical Center

PhasePhase 2
Planned participants183
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

No study to date has compared topical DTZ to MEBO ointment in the treatment of anal fissure. Therefore, the present study aims to compare the efficacy and safety of DTZ to MEBO in the treatment of acute anal fissure. The investigators propose to conduct a comparative randomized clinical study. In this study, the investigators will compare patients with acute anal fissure receiving MEBO ointment vs Topical DTZ ointment vs a combination of MEBO and DTZ ointment. Hypothesis: MEBO in combination with DTZ is more effective than DTZ or MEBO alone in the treatment of acute anal fissure.

This description comes directly from the study's public registry record.

Talk to the study team

Eman Sbaity, MD  ·  +961-76-110882  ·  es25@aub.edu.lb

Mohamad Hadi El Charif, MD  ·  +961-3-771917  ·  mohamadhadi.elcharif@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

American University of BeirutBeirut, LebanonRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04153032